[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-340927-105":59,"doc-detail-340927-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","hpv-associated-oropharyngeal-cancer-in-search-of-surrogate-biomarkers-for-early-lesions","HPV-associated oropharyngeal cancer - in search of surrogate biomarkers for early lesions","","HPV-associated oropharyngeal squamous cell carcinoma (OPSCC) is rising globally, with high-risk human papillomavirus acting as a primary driver. Early screening is needed, yet premalignant lesions of OPSCC are poorly characterized, limiting the discovery of reliable surrogate biomarkers. This review synthesizes literature on the multistep progression from oral HPV infection and persistence to tumor development, outlines barriers to identifying premalignant disease, and evaluates emerging experimental and model-based strategies.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/hpv-associated-oropharyngeal-cancer-in-search-of-surrogate-biomarkers-for-early-lesions/340927/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/hpv-associated-oropharyngeal-cancer-in-search-of-surrogate-biomarkers-for-early-lesions/340927.png","ImageObject",300,407,{"name":92,"@type":93},"Patrick","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is early screening for HPV-associated OPSCC challenging?","Question",{"text":112,"@type":113},"Early detection is hindered by limited understanding of premalignant lesions and by the restricted availability of biomarkers that can reliably identify high-risk individuals before cancer develops.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What factors have historically been linked to OPSCC, and what is the current main driver?",{"text":117,"@type":113},"Historically, OPSCC was associated with tobacco and alcohol. Current evidence points to high-risk human papillomaviruses (HPV) as the main cause of the marked increase in incidence.",{"name":119,"@type":110,"acceptedAnswer":120},"What is the goal of surrogate biomarkers in this context?",{"text":121,"@type":113},"Surrogate biomarkers aim to indicate elevated risk for OPSCC by reflecting earlier precancerous processes, particularly those associated with HPV infection, persistence, and progression.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},340927,1790813817,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":41,"preview_page_count":19,"preview_urls":145},549758146520,"https://ap-avatar.wpscdn.com/avatar/80002397d8c0411e94?_k=1775819394049821470","Oncogene [www.nature.com/onc](www.nature.com/onc)  \nREVIEW ARTICLE OPEN   \nHPV-associated oropharyngeal cancer: in search of surrogate biomarkers for early lesions  \nYvonne X. Lim 1 and Nisha J. D’Silva 1,2,3 ✉  \n© The Author(s) 2024  \n|  |  |  |\n| --- | --- | --- |\n|  | The incidence of oropharyngeal cancer (OPSCC) has escalated in the past few decades; this has largely been triggered by high-risk human papillomavirus (HPV) . Early cancer screening is needed for timely clinical intervention and may reduce mortality and morbidity, but the lack of knowledge about premalignant lesions for OPSCC poses a signiﬁcant challenge to early detection. Biomarkers that identify individuals at high risk for OPSCC may act as surrogate markers for precancer but these are limited as only a few studies decipher the multistep progression from HPV infection to OPSCC development. Here, we summarize the current literature describing the multistep progression from oral HPV infection, persistence, and tumor development in the oropharynx. We also examine key challenges that hinder the identiﬁcation of premalignant lesions in the oropharynx and discuss potential biomarkers for oropharyngeal precancer. Finally, we evaluate novel strategies to improve investigations of the biological process that drives oral HPV persistence and OPSCC, highlighting new developments in the establishment of a genetic progression model |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n|  |  |  |\n| for HPV + OPSCC and in vivo models that mimic HPV + OPSCC pathogenesis. |  |  |\n|  | Oncogene (2024) 43:543–554; [https://doi.org/10.1038/s41388-023-02927-9](https://doi.org/10.1038/s41388-023-02927-9) |  |\n|  |  |  |\n\nINTRODUCTION  \nOropharyngeal cancers occur in the tonsils, base of tongue, soft palate, and posterior pharyngeal wall. Like other head and necksquamous cell carcinomas (HNSCC), over 95% of oropharyngeal cancers arise from squamous cells in the mucosal lining epithelium and are known as oropharyngeal squamous cell carcinoma (OPSCC) [1, 2] . Globally, OPSCC accounts for 11% of all HNSCCs; this incidence falls signiﬁcantly behind oral cavity cancer, the predominant subsite for HNSCCs (over 40%) (Fig. 1A) . Nonetheless, the clinical and scientiﬁc focus on OPSCC is due to its rapidly increasing prevalence especially in high-income and developed countries [3–6] (Figs. 1B, C and 2) . Since the global incidence and mortality rates of OPSCC are expected to rise by approximately 50% in the next 20 years (Fig. 1C), there is a dire need to better understand the disease course to aid in prevention, early detection, and treatment.  \nHistorically, OPSCC was associated with tobacco and alcohol consumption [3] . However, overwhelming evidence now points toward high-risk human papillomaviruses (HPV) as the main culprits driving the dramatic rise in incidence of OPSCC [3, 4, 7] . In the United States, the proportion of OPSCCs that are positive for HPV (HPV + OPSCC) increased from 16% in the 1980s to more than 70% in the early 2000s [3, 8] . In 2011, it was predicted that OPSCC would surpass cervical cancer to become the most common HPV+ malignancy in the United States by 2020 [3]; this occurred in 2012 [9] . In the United Kingdom, HPV + OPSCC surpassed cervical cancer in 2016 [9] . Similar trends were observed in European countries including Germany, Sweden, and Denmark [6, 10, 11] . In contrast, there is a decline in HPV-negative [HPV(-)] OPSCC [3, 4] . Among all  \nhead and neck regions, HPV-induced tumorigenesis favors the oropharynx; the fraction of HPV+ cancers remains markedly low at non-oropharyngeal subsites [12–14] . Moreover, HPV + OPSCC is more common among white males and non-smokers [14], but there is a rising trend in women and non-white people as well [15, 16] . Several studies revealed that patients with HPV + OPSCC who have tobacco exposure are at higher risk for recurrence [17, 18] . Patients with HPV + OPSCC are generally you","cbCaipSllDU2PAqu","https://ap.wps.com/l/cbCaipSllDU2PAqu","pdf",3336134,12,"English","# Introduction\n## Epidemiology and risk shifts\n## HPV-driven tumorigenesis and clinical patterns\n## Current screening limitations and need for biomarkers","[{\"question\":\"Why is early screening for HPV-associated OPSCC challenging?\",\"answer\":\"Early detection is hindered by limited understanding of premalignant lesions and by the restricted availability of biomarkers that can reliably identify high-risk individuals before cancer develops.\"},{\"question\":\"What factors have historically been linked to OPSCC, and what is the current main driver?\",\"answer\":\"Historically, OPSCC was associated with tobacco and alcohol. Current evidence points to high-risk human papillomaviruses (HPV) as the main cause of the marked increase in incidence.\"},{\"question\":\"What is the goal of surrogate biomarkers in this context?\",\"answer\":\"Surrogate biomarkers aim to indicate elevated risk for OPSCC by reflecting earlier precancerous processes, particularly those associated with HPV infection, persistence, and progression.\"}]","HPV-associated oropharyngeal cancer - in search of surrogate biomarkers for early lesions | PDF",1790039575,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f59109fe1934565c3ad04d85e04bbe83.webp",983,1305,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7ca19392d36648e1edb1b73c56709af9.webp",982,1304,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/373e2cf659e1631932a7389954b65b33.webp",981,1303,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/090c3b31a4dbffceee2660720e185549.webp",980,1301]